Changes of autonomic information flow due to idiopathic dilated cardiomyopathy

Manuel Palacios1, Holger Friedrich, Christine Götze

  • 1Dep. ESAII, Centre for Biomedical Engineering Research, Technical University of Catalonia, Barcelona, Spain.

Insights

Autonomic information flow (AIF) measures show promise in predicting risk for patients with idiopathic dilated cardiomyopathy (IDC). This novel approach may improve upon traditional heart rate variability (HRV) analysis for risk stratification.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Nonlinear Dynamics

Background:

  • Risk stratification in idiopathic dilated cardiomyopathy (IDC) is crucial but challenging with conventional heart rate variability (HRV) analysis.
  • Cardiovascular system adjustments involve complex, nonlinear mechanisms potentially offering additional prognostic insights.

Purpose of the Study:

  • To explore the prognostic value of autonomic information flow (AIF) measures in IDC patients.
  • To compare the efficacy of AIF measures against conventional HRV for risk stratification in IDC.

Main Methods:

  • Analysis of Holter recordings from 32 IDC patients (10 high-risk, 22 low-risk) and 12 normal subjects.
  • Evaluation of a comprehensive set of AIF measures and conventional HRV metrics.
  • Statistical analysis including sensitivity, specificity, ROC characteristics, and Spearman's rank correlation.

Main Results:

  • Most AIF measures demonstrated discriminatory value between IDC patients and normal subjects, unlike most traditional HRV measures.
  • Conventional HRV metrics like SDNN and frequency band measures differentiated high-risk from low-risk IDC patients.
  • The AIF measure, peak decay (PD(dHF)), reflecting HF band information flow, showed significant prognostic value.

Conclusions:

  • Autonomic information flow (AIF) measures, particularly PD(dHF), show potential for improving risk stratification in IDC.
  • AIF analysis may offer added value beyond traditional HRV metrics like SDNN.
  • Further comprehensive clinical studies are needed to validate these findings.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...